Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

NYSTATIN

All products: general benefit

Other products in the same Health Canada class (D01A) — coverage varies; not interchangeable

  • Clotrimazole (Clotrimaderm): general benefit, Not a benefit
  • Ketoconazole (Nizoral): general benefit, Not a benefit
  • Miconazole nitrate (Micatin): general benefit
  • Terbinafine (Lamisil): general benefit
  • Ciclopirox (Penlac): not a benefit
  • Betamethasone dipropionate + clotrimazole (Lotriderm Cream): not a benefit

Nyaderm · DIN 00716871 · 100000U/g · Cr

General benefitMarketed · checked 2026-09-19
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Nyaderm · DIN 00716871 Manufacturer: Taro Pharmaceuticals Inc.; listing date 1996-10-01 Health Canada: Marketed since 1979-12-31 · brand NYADERM · ATC D01AA01 NYSTATIN · form Cream · route Topical · ingredients NYSTATIN 100000 UNIT/G · company Space age brands · schedule Non-prescription drugs
Check this DIN again · Health Canada product record

Nyaderm: Formulary list price $0.2037/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2037 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8977 · Verify on the e-Formulary ↗ (DIN 00716871)

Source record
DIN 00716871: Nyaderm Raw flags: sec3=Y Item: 840408004; group id 823; item number 2005; lccId None; manufacturer id TAR Source form: Cr; strength: 100000U/g Recorded listing: General benefit Source prices (unrounded): $0.2037; ministry $0.2037 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00716871 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8977 Therapeutic Notes (formulary) Nystatin is not effective in the treatment of Dermatophyte infections or Tinea versicolor.
Interchangeable products
Mycostatin · DIN 00029092 · not recorded
Shortage status: not checked (no credentials)
Other drugs in the same formulary class (84:04:08 Fungicides) and how they are covered

Matched class: 84:04:08 Fungicides

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: MICONAZOLE NITRATE, TERBINAFINE HCL Some products covered without a code (check the product listing): CLOTRIMAZOLE, KETOCONAZOLE, TERCONAZOLE 84:04:08 Fungicides

CLOTRIMAZOLE

· 7 products · General benefit (6), Listed, not a benefit (1) · strengths: 10mg/g, 500mg & 1%, 20mg/g · Cr, Tab & Cr, Vag Cr-App

KETOCONAZOLE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 2% · Cr

MICONAZOLE NITRATE

· 1 products · General benefit · strengths: 2% · Cr

TERBINAFINE HCL

· 1 products · General benefit · strengths: 1% · Cr

CICLOPIROX

· 3 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 8% W/W · Top Sol

CLOTRIMAZOLE & BETAMETHASONE DIPROPIONATE

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 1% w/w & 0.05% w/w · Top Cr

TERCONAZOLE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 0.4% · Vag Cr

FLUCONAZOLE

· 8 products · Limited Use, codes 235 · strengths: 150mg · Cap Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 84:04:08
Full class listing Related classes: 84:04:04 Antibiotics, 84:04:12 Parasiticides, 84:04:16 Other Anti-Infectives Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
Product monograph unavailable: no link